Calidi Biotherapeutics, Inc.
CLDI- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001855485
No open-market purchases or sales by Calidi Biotherapeutics, Inc. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $89.3K in total; no superinvestor holds it.
Other share classesCLDWW
13F holders, Q3 2025
Institutional positions in Calidi Biotherapeutics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- −12 vs. Q2 2025
- Shares held
- 232.5K
- −2.61M (−91.8%) vs. Q2 2025
- Total value
- $353.6K
- −$300.3K (−45.9%) vs. Q2 2025
- New holders
- 5
- 0 more added
- Sold out
- 17
- 17 more reduced
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLDI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 23 | $89.3K |
| Q1 2026 | 28 | $478.8K |
| Q4 2025 | 27 | $524.7K |
| Q3 2025 | 22 | $353.6K |
| Q2 2025 | 35 | $656.8K |
| Q1 2025 | 36 | $3.09M |
| Q4 2024 | 33 | $1.27M |
| Q3 2024 | 20 | $363.4K |
| Q2 2024 | 32 | $523.2K |
| Q1 2024 | 31 | $1.56M |
| Q4 2023 | 25 | $3.29M |
| Q3 2023 | 13 | $3.54M |
| Q2 2023 | 25 | $40.6M |
| Q1 2023 | 27 | $45.8M |
| Q4 2022 | 25 | $39.6M |
| Q3 2022 | 21 | $36.1M |
| Q2 2022 | 42 | $214.8M |
| Q1 2022 | 40 | $202.4M |
| Q4 2021 | 27 | $184.1M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Calidi Biotherapeutics, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| HighTower Advisors, LLC | 84,956 | $129.1K | 0.00% | −34,515−28.9% | Reduced |
| Belpointe Asset Management LLC | 41,642 | $63.3K | 0.00% | −208,191−83.3% | Reduced |
| Vanguard Group Inc | 34,728 | $52.8K | 0.00% | −318,652−90.2% | Reduced |
| Geode Capital Management, LLC | 29,595 | $45.0K | 0.00% | −202,981−87.3% | Reduced |
| Warberg Asset Management LLC | 18,705 | $28.4K | 0.01% | +18,705 | New |
| RS Crum Inc. | 15,256 | $23.2K | 0.01% | +15,256 | New |
| UBS Group AG | 2,564 | $3.90K | 0.00% | −42,338−94.3% | Reduced |
| Finepoint Capital LP | 1,042 | $1.58K | 0.00% | −11,457−91.7% | Reduced |
| Highbridge Capital Management LLC | 1,042 | $1.58K | 0.00% | −11,459−91.7% | Reduced |
| Apollo Management Holdings, L.P. | 1,042 | $1.58K | 0.00% | +1,042 | New |
| Royal Bank of Canada | 417 | $1.00K | 0.00% | −4,583−91.7% | Reduced |
| Morgan Stanley | 387 | $588 | 0.00% | −1,532−79.8% | Reduced |
| Barrett & Company, Inc. | 292 | $444 | 0.00% | −3,208−91.7% | Reduced |
| Advisor Group Holdings, Inc. | 400 | $377 | 0.00% | −26,353−98.5% | Reduced |
| FMR LLC | 125 | $190 | 0.00% | +125 | New |
| Tradewinds Capital Management, LLC | 101 | $154 | 0.00% | −899−89.9% | Reduced |
| Reyes Financial Architecture, Inc. | 100 | $152 | 0.00% | +100 | New |
| SBI Securities Co., Ltd. | 46 | $70 | 0.00% | −514−91.8% | Reduced |
| CVA Family Office, LLC | 42 | $64 | 0.00% | −458−91.6% | Reduced |
| Bank of America Corp | 30 | $46 | 0.00% | −296−90.8% | Reduced |
| JPMorgan Chase & Co | 9 | $14 | 0.00% | −54−85.7% | Reduced |
| Evermay Wealth Management LLC | 1 | $2 | 0.00% | −6,341−100.0% | Reduced |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −792,000−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −422,500−100.0% | Sold out |
| CPR Investments Inc. | 0 | $0 | 0.00% | −101,000−100.0% | Sold out |
| Red Wave Investments LLC | 0 | $0 | 0.00% | −80,828−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −71,196−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −61,290−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −48,693−100.0% | Sold out |
| Drive Wealth Management, LLC | 0 | $0 | 0.00% | −45,000−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −43,609−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −31,100−100.0% | Sold out |
| Delta Investment Management, LLC | 0 | $0 | 0.00% | −21,023−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −13,205−100.0% | Sold out |
| Commonwealth Equity Services, LLC | 0 | $0 | 0.00% | −13,500−100.0% | Sold out |
| Avidian Wealth Solutions, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −8,937−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −10,240−100.0% | Sold out |
| BlackRock, Inc. | 0 | $0 | 0.00% | −259−100.0% | Sold out |
| Grassi Investment Management | – | – | – | – | Not filed |